Alto Neuroscience
About:
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Website: https://www.altoneuroscience.com
Twitter/X: altoneuro
Top Investors: Eli Lilly, Stanford University, Franklin Templeton, Point72 Ventures, Alexandria Venture Investments
Description:
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
$239M
$10M to $50M
Los Altos, California, United States
2019-01-01
info(AT)altoneuroscience.com
Amit Etkin, Dan Segal, Wei Wu
11-50
2023-11-21
Public
© 2024 MyAiNote.com